MF
ABBV icon

Manchester Financial’s AbbVie ABBV Stock Holding History

Manchester Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$965K Sell
3,834
-246
-6% -$52.9K 0.17% 55
2026
Q1 		$887K Sell
4,080
-193
-5% -$42.8K 0.17% 60
2025
Q4 		$976K Sell
4,273
-1
-0% -$228 0.18% 60
2025
Q3 		$990K Buy
4,274
+1
+0% +$204 0.2% 61
2025
Q2 		$793K Buy
4,273
+11
+0.3% +$2.04K 0.17% 59
2025
Q1 		$893K Sell
4,262
-281
-6% -$54.6K 0.2% 49
2024
Q4 		$807K Sell
4,543
-4
-0.1% -$735 0.18% 47
2024
Q3 		$898K Buy
4,547
+33
+0.7% +$6.16K 0.19% 44
2024
Q2 		$774K Buy
4,514
+102
+2% +$16.9K 0.19% 44
2024
Q1 		$804K Buy
4,412
+156
+4% +$26.9K 0.21% 44
2023
Q4 		$659K Sell
4,256
-179
-4% -$26.1K 0.18% 46
2023
Q3 		$661K Sell
4,435
-111
-2% -$16.3K 0.19% 44
2023
Q2 		$612K Sell
4,546
-15
-0.3% -$2.2K 0.17% 47
2023
Q1 		$727K Sell
4,561
-70
-2% -$10.7K 0.21% 42
2022
Q4 		$748K Sell
4,631
-273
-6% -$41.9K 0.2% 44
2022
Q3 		$658K Sell
4,904
-69
-1% -$9.9K 0.19% 44
2022
Q2 		$762K Sell
4,973
-32
-0.6% -$4.89K 0.29% 43
2022
Q1 		$811K Sell
5,005
-2,136
-30% -$310K 0.29% 40
2021
Q4 		$967K Buy
7,141
+624
+10% +$73.7K 0.34% 41
2021
Q3 		$703K Buy
6,517
+298
+5% +$34.1K 0.27% 43
2021
Q2 		$701K Buy
6,219
+3,478
+127% +$392K 0.28% 44
2021
Q1 		$297K Buy
2,741
+958
+54% +$102K 0.14% 57
2020
Q4 		$191K Buy
1,783
+117
+7% +$11.2K 0.12% 61
2020
Q3 		$146K Buy
1,666
+332
+25% +$31.3K 0.11% 63
2020
Q2 		$131K Buy
1,334
+25
+2% +$2.2K 0.11% 71
2020
Q1 		$100K Sell
1,309
-145
-10% -$12.4K 0.07% 82
2019
Q4 		$129K Buy
+1,454
New +$121K 0.05% 79
2019
Q3 		– Sell
-1,489
Closed -$108K – 63
2019
Q2 		$108K Buy
+1,489
New +$117K 0.05% 82

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Manchester Financial's ABBV Position: Q2 2026 in Review

Manchester Financial reduced its AbbVie (ABBV) stake by 6% in Q2 2026, selling an estimated $52.9K and leaving 3,834 shares worth $965K. The position accounts for 0.17% of the portfolio, ranked #55.

Manchester Financial first reported a position in ABBV in Q2 2019 and has held it in 28 quarters since. The position peaked at $990K in Q3 2025. 2,103 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Manchester Financial held 3,834 shares of AbbVie worth $965K as of Q2 2026.
  • Manchester Financial sold 246 AbbVie shares in Q2 2026, an estimated $52.9K.
  • AbbVie made up 0.17% of Manchester Financial's portfolio in Q2 2026, its #55 holding.
  • Manchester Financial first reported a position in AbbVie in Q2 2019 and has held it in 28 quarters since.
  • Manchester Financial's AbbVie position peaked at $990K in Q3 2025.
  • 2,103 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Manchester Financial's 13F filing for Q2 2026, filed 17 Jul 2026.